DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-799 Cr | ₹-799 Cr | ₹-797 Cr | ₹-532 Cr | ₹-35 Cr |
What is the latest Cash Flow from Financing Activities ratio of DIVIS LABORATORIES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2025 | ₹-799 Cr |
Mar2024 | ₹-799 Cr |
Mar2023 | ₹-797 Cr |
Mar2022 | ₹-532 Cr |
Mar2021 | ₹-35 Cr |
How is Cash Flow from Financing Activities of DIVIS LABORATORIES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹-799 Cr | Negative | |
Mar2024 | ₹-799 Cr | Negative | |
Mar2023 | ₹-797 Cr | Negative | |
Mar2022 | ₹-532 Cr | Negative | |
Mar2021 | ₹-35 Cr | - |
Compare Cash Flow from Financing Activities of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹181,323.2 Cr | -0.2% | 4.5% | 49.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,091.0 Cr | 2.3% | 3.2% | 9.5% | Stock Analytics | |
CIPLA | ₹119,038.0 Cr | -0.2% | -2% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹117,170.0 Cr | 3.7% | 6.5% | 16.6% | Stock Analytics | |
MANKIND PHARMA | ₹108,281.0 Cr | 3.2% | 11.5% | 23.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,061.0 Cr | -0% | -4.6% | -6.2% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -0.2% |
4.5% |
49.6% |
SENSEX | -1.1% |
1% |
3.4% |
You may also like the below Video Courses